HAMPHARMA
0423.277.613 · rovalta.com · 22/09/2026
HAMPHARMA
Overview
What does HAMPHARMA do?
HAMPHARMA is a Private limited company incorporated in 1982. Its registered office is in Tessenderlo-Ham. It employs on average 2,7 ETP workers (FTE).
3945 Tessenderlo-Ham · FlandreSee on map
Joint committees (1)
- 313
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Gross margin | 504 k € | +3.8% | 485,4 k € | +2.8% | 472,2 k € | +12.0% | 421,5 k € | +8.2% | 389,6 k € | +50.3% | 259,3 k € | -17.0% | 312,2 k € | -7.0% | 335,6 k € | +14.0% | 294,5 k € | -5.1% | 310,4 k € | -1.3% | 314,4 k € | +6.5% | 295,3 k € | +0.7% | 293,3 k € | +5.5% | 278,1 k € | +2.2% | 272,3 k € | +4.6% | 260,4 k € | -4.3% | 272,1 k € | +14.0% | 238,7 k € | -11.1% | 268,3 k € | +14.9% | 233,6 k € |
| EBITDA | 323,4 k € | +16.9% | 276,7 k € | -10.0% | 307,6 k € | +9.2% | 281,8 k € | +2.0% | 276,4 k € | +54.9% | 178,4 k € | -15.8% | 211,9 k € | -3.6% | 219,9 k € | +26.3% | 174,1 k € | -14.8% | 204,3 k € | +13.0% | 180,8 k € | +10.1% | 164,2 k € | +3.7% | 158,4 k € | +10.6% | 143,2 k € | +3.5% | 138,4 k € | +9.9% | 126 k € | -4.5% | 131,8 k € | +6.4% | 123,9 k € | -29.8% | 176,6 k € | +22.1% | 144,6 k € |
| Operating result | 213,3 k € | -12.2% | 242,9 k € | -19.0% | 300 k € | +8.9% | 275,5 k € | +3.4% | 266,4 k € | +57.3% | 169,4 k € | -16.6% | 203 k € | -3.5% | 210,5 k € | +26.4% | 166,5 k € | -15.5% | 197,1 k € | +13.7% | 173,4 k € | +9.9% | 157,7 k € | +5.9% | 148,9 k € | +11.7% | 133,3 k € | +2.2% | 130,4 k € | +12.5% | 115,9 k € | -2.2% | 118,5 k € | +2.8% | 115,2 k € | -31.8% | 169 k € | +24.6% | 135,6 k € |
| Net result | 143,5 k € | -34.4% | 218,6 k € | -26.7% | 298,1 k € | +9.4% | 272,6 k € | +64.3% | 165,9 k € | -13.7% | 192,2 k € | -20.2% | 241 k € | -3.1% | 248,8 k € | +23.9% | 200,7 k € | -15.0% | 236,1 k € | +9.9% | 214,9 k € | +9.9% | 195,5 k € | +1.7% | 192,3 k € | +14.8% | 167,5 k € | -0.9% | 168,9 k € | +5.3% | 160,5 k € | -25.2% | 214,4 k € | +37.3% | 156,2 k € | +30.9% | 119,3 k € | +24.1% | 96,1 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 30,8 k € | +3.5% | 29,8 k € | +2.2% | 29,1 k € | +0.4% | 29 k € | +0.4% | 28,9 k € | +0.1% | 28,9 k € | +0.1% | 28,8 k € | +0.1% | 28,8 k € | +2.8% | 28 k € | +0.8% | 27,8 k € | +4.3% | 26,7 k € | +3.4% | 25,8 k € | +2.1% | 25,3 k € | +1.0% | 25 k € | +2.0% | 24,5 k € | +4.0% | 23,6 k € | -89.0% | 215,1 k € | -28.5% | 300,7 k € | +2.8% | 292,6 k € | +15.5% | 253,2 k € |
| Total assets | 2 M € | +13.0% | 1,7 M € | +165% | 661,2 k € | +19.1% | 555,4 k € | +9.7% | 506,3 k € | +1.9% | 496,8 k € | -6.2% | 529,8 k € | +17.1% | 452,3 k € | -1.2% | 458 k € | -14.6% | 536,3 k € | +3.8% | 516,8 k € | +5.8% | 488,6 k € | +4.6% | 466,9 k € | +0.2% | 466 k € | -3.1% | 480,8 k € | -5.2% | 507 k € | -4.0% | 527,9 k € | -5.3% | 557,1 k € | +5.8% | 526,4 k € | +24.8% | 421,9 k € |
| Cash | 303,8 k € | +5.8% | 287,1 k € | +12.3% | 255,7 k € | +7.9% | 237 k € | +60.4% | 147,8 k € | -29.7% | 210 k € | +2.7% | 204,6 k € | +16.3% | 175,9 k € | -8.8% | 192,9 k € | -24.0% | 253,8 k € | +18.0% | 215,1 k € | -4.1% | 224,4 k € | +16.7% | 192,2 k € | -1.8% | 195,7 k € | -7.9% | 212,4 k € | +5.3% | 201,7 k € | -8.1% | 219,3 k € | +54.3% | 142,2 k € | -8.0% | 154,6 k € | -21.7% | 197,3 k € |
| Debts | 1,9 M € | +12.3% | 1,7 M € | +176% | 623,3 k € | +20.6% | 516,9 k € | +9.3% | 473 k € | +4.4% | 453,3 k € | -9.4% | 500,2 k € | +18.7% | 421,5 k € | -1.5% | 427,8 k € | -15.7% | 507,3 k € | +3.9% | 488,1 k € | +5.6% | 462,1 k € | +4.8% | 441 k € | +0.5% | 439,1 k € | -3.6% | 455,4 k € | -5.6% | 482,4 k € | +54.9% | 311,4 k € | +21.4% | 256,4 k € | +9.7% | 233,9 k € | +38.7% | 168,5 k € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 2,7 ETP | -3.6% | 2,8 ETP | 0.0% | 2,8 ETP | -3.4% | 2,9 ETP | +3.6% | 2,8 ETP | +47.4% | 1,9 ETP | +11.8% | 1,7 ETP | -15.0% | 2,0 ETP | -9.1% | 2,2 ETP | 0.0% | 2,2 ETP | +10.0% | 2,0 ETP | 0.0% | 2,0 ETP | 0.0% | 2,0 ETP | 0.0% | 2,0 ETP | 0.0% | 2,0 ETP | 0.0% | 2,0 ETP | 0.0% | 2,0 ETP | 0.0% | 2,0 ETP | 0.0% | 2,0 ETP | 0.0% | 2,0 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 10 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/07/2026 | 28/08/2025 | 28/08/2024 | 30/08/2023 | 28/08/2022 | 09/08/2021 |
| General meeting | 30/06/2026 | 30/05/2025 | 31/05/2024 | 26/05/2023 | 27/05/2022 | 28/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 27/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/05/2025 | 28/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 31/05/2024 | 28/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 26/05/2023 | 30/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 27/05/2022 | 28/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 28/05/2021 | 09/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 31/08/2020 | 04/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 31/05/2019 | 25/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 25/05/2018 | 25/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 26/05/2017 | 21/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 27/05/2016 | 28/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 29/05/2015 | 24/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/05/2014 | 28/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 31/05/2013 | 12/06/2013 | Dutch | |
| Abridged model | 31/12/2011 | 25/05/2012 | 20/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 27/05/2011 | 14/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 28/05/2010 | 24/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 19/06/2009 | 16/07/2009 | Dutch | |
| Abridged model | 31/12/2007 | 30/05/2008 | 27/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 25/05/2007 | 21/06/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 10 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Registered office27/03/2025MAATSCHAPPELIJKE ZETEL
- Mandates29/08/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Registered office24/10/2016MAATSCHAPPELIJKE ZETEL
- Capital / shares20/10/2004KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025143,5 k €↓
- 2024Annual accounts 2024218,6 k €↓
- 2024Name changeHampharma
- 2023Annual accounts 2023298,1 k €↑
- 2022Annual accounts 2022272,6 k €↑
- 2021Annual accounts 2021165,9 k €↓
- 2021Name changeApoteek DEPLOIGE
- 2020Annual accounts 2020192,2 k €↓
- 2019Annual accounts 2019241 k €↓
- 2018Annual accounts 2018248,8 k €↑
- 2017Annual accounts 2017200,7 k €↓
- 2016Annual accounts 2016236,1 k €↑
- 2015Annual accounts 2015214,9 k €↑
- 2014Annual accounts 2014195,5 k €↑
- 2013Annual accounts 2013192,3 k €↑
- 2012Annual accounts 2012167,5 k €↓
- 2011Annual accounts 2011168,9 k €↑
- 2010Annual accounts 2010160,5 k €↓
- 2009Annual accounts 2009214,4 k €↑
- 2008Annual accounts 2008156,2 k €↑
- 2007Annual accounts 2007119,3 k €↑
- 2006Annual accounts 200696,1 k €
- 01/07/1982IncorporationPrivate limited company